<i>Mycobacterium tuberculosis</i> sulfurtransferase <scp>SseA</scp> is activated by its neighboring gene product Rv3284
Resumen: Tuberculosis remains a critical global health challenge, which underscores the need for new therapeutic targets. A potential drug target is the rhodanese‐like thiosulfate sulfurtransferase SseA, which plays a role in macrophage infection by Mycobacterium tuberculosis (Mtb) and its resistance to oxidative stress. In our research, we identified a protein (Rv3284), herein referred to as SufEMtb, that interacts with SseA and modulates its activity. Sequence analysis and molecular modeling revealed that SufEMtb enhances SseA enzymatic function by binding to its non‐catalytic N‐terminal domain and favoring an activating conformational change in a regulatory loop of SseA. This interaction appears crucial for effective enzyme activity and the maintenance of redox homeostasis in Mtb, making the SseA–SufEMtb complex a potential target for new therapies.
Idioma: Inglés
DOI: 10.1002/1873-3468.70117
Año: 2025
Publicado en: FEBS Letters (2025), [15 pp.]
ISSN: 0014-5793

Financiación: info:eu-repo/grantAgreement/ES/DGA-FEDER/E35-23R
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PID2022-136369NB-I00
Tipo y forma: Article (Published version)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)
Exportado de SIDERAL (2025-10-17-14:14:12)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > bioquimica_y_biologia_molecular



 Notice créée le 2025-08-26, modifiée le 2025-10-17


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)